Cerebral Ischemia clinical trials

Explore recruiting cerebral ischemia clinical trials.

Recruiting cerebral ischemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cerebral Ischemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Improving outcome in subarachnoid hemorrhage with nadroparin

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS <6) based on MRI criteria (DWIFLAIR mismatch)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

TicAgreLor versus placebo to prevent cerebral ISCHemia in anEuRysmal low grade SAH A double blinded randomised controlled study TALISCHER - SAH

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cerebral hemodynamic optimization by milrinone for the prevention of delayed cerebral ischemia in severe subarachnoid hemorrhage -OPTIMIL Study-

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Is adding Cilostazol to nimodipine improving neurological outcome of patients with Aneurysmal Subarachnoid Hemorrhage? A randomized, double blind, placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

SHORT RUN AF. Rivaroxaban versus standard of care for patients with excessive atrial ectopy or short atrial runs and high embolism risk

France

Phase III and phase IV (Integrated) EU CTIS Study details

Cerebral Ischemia trials by city

Cerebral Ischemia in Toronto Cerebral Ischemia in Vancouver Cerebral Ischemia in Montreal Cerebral Ischemia in Calgary Cerebral Ischemia in Edmonton Cerebral Ischemia in Ottawa Cerebral Ischemia in Winnipeg Cerebral Ischemia in Quebec City Cerebral Ischemia in Hamilton Cerebral Ischemia in Kitchener Cerebral Ischemia in London Cerebral Ischemia in Halifax Cerebral Ischemia in New York Cerebral Ischemia in Los Angeles Cerebral Ischemia in Chicago Cerebral Ischemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease